The first international recommendations and guidelines for the care of sibling stem cell donors were established in 2010, and have not yet been evaluated. However, a model for information and care of adult potential sibling stem cell donors (the IC model) developed and introduced at the Skåne University Hospital, Lund, Sweden, in 2005 conforms closely to them. The IC model aims to protect the privacy of potential donors, support and respect their free choice, and identify quickly those unwilling or unable to donate and thus minimize delay in seeking alternative donors. To evaluate the IC model a questionnaire survey in 2010 gathered the perceptions and views on information provision; influences over decision making; and care provision under...
Allogeneic haematopoietic cell transplantation (HCT) is a curative procedure for patients with haema...
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem c...
Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access...
The first international recommendations and guidelines for the care of sibling stem cell donors were...
BACKGROUND: There is a lack of knowledge about sibling stem cell donors' experiences pre-donation...
AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each y...
Allogeneic haematopoietic stem cell transplantation (hereafter HSCT) is an established treatment whi...
There is a lack of knowledge about sibling stem cell donors' experiences pre-donation and the waitin...
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year cont...
Objective: What and when should we tell sibling donors about the donation process? Although we provi...
Background: There is a lack of theoretical framework supporting stem cell transplant nurses in their...
Purpose: When healthy children/adolescents are potential stem cell donors to a sibling, ethical ques...
Purpose: When healthy children/adolescents are potential stem cell donors to a sibling, ethical ques...
Background: Allogen stem cell transplantation is an established treatment for manylife-threatening d...
Background: There is limited knowledge about the perspective of patients undergoing allogeneic haema...
Allogeneic haematopoietic cell transplantation (HCT) is a curative procedure for patients with haema...
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem c...
Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access...
The first international recommendations and guidelines for the care of sibling stem cell donors were...
BACKGROUND: There is a lack of knowledge about sibling stem cell donors' experiences pre-donation...
AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each y...
Allogeneic haematopoietic stem cell transplantation (hereafter HSCT) is an established treatment whi...
There is a lack of knowledge about sibling stem cell donors' experiences pre-donation and the waitin...
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year cont...
Objective: What and when should we tell sibling donors about the donation process? Although we provi...
Background: There is a lack of theoretical framework supporting stem cell transplant nurses in their...
Purpose: When healthy children/adolescents are potential stem cell donors to a sibling, ethical ques...
Purpose: When healthy children/adolescents are potential stem cell donors to a sibling, ethical ques...
Background: Allogen stem cell transplantation is an established treatment for manylife-threatening d...
Background: There is limited knowledge about the perspective of patients undergoing allogeneic haema...
Allogeneic haematopoietic cell transplantation (HCT) is a curative procedure for patients with haema...
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem c...
Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access...